Filing Flows › Cannapharmarx (CPMD) › Q2 2026 › vs Q2 2025
Cannapharmarx (CPMD) Q2 2026 vs Q2 2025 (year over year)
Cannapharmarx's revenue rose $45K (+19%) from $232K in Q2 2025 to $276K in Q2 2026.
Cannapharmarx, Q2 2026: revenue $276K (+19% year over year), operating margin -137.1%, net loss $1.9M, operating cash flow −$127K. The chart draws each line against Q2 2025, the increases inside each band.
Every line
| Line | Q2 2026 | Q2 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $276K | $232K | $45K | +19% |
| Net loss | $1.9M | $1.4M | $496K | +35% |
| Costs & expenses | $2.2M | $1.6M | $540K | +33% |
| Operating costs | $655K | $1.1M | −$418K | -39% |
| Interest & other, net | $1.5M | $572K | $958K | +167% |
| Cost of revenue | $415K | $853K | −$438K | -51% |
| General & admin | $83K | $76K | $7K | +9% |
| Other operating costs | $158K | $144K | $14K | +10% |
| Operating cash sources | $1.9M | $1.4M | $496K | +35% |
| Working capital & other | $1.8M | $967K | $815K | +84% |
| Cash used in operations | $127K | $446K | −$319K | -71% |
| Net loss absorbed | $1.9M | $1.4M | $496K | +35% |
Questions
How much did Cannapharmarx's revenue grow year over year in Q2 2026?
Cannapharmarx's revenue rose $45K (+19%) from $232K in Q2 2025 to $276K in Q2 2026.